Dow Up0.19% Nasdaq Up0.14%

Lexicon Pharmaceuticals, Inc. (LXRX)

-NasdaqGS
1.48 Down 0.01(0.67%) 10:16AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 676   277   1,410   238  
Cost of Revenue -   -   -   -  
Gross Profit 676   277   1,410   238  
Operating Expenses
Research Development21,187  23,953  20,263  25,400  
Selling General and Administrative5,600  6,796  (1,877)6,054  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (26,111) (30,472) (16,976) (31,216)
Income from Continuing Operations
Total Other Income/Expenses Net538  94  39  50  
Earnings Before Interest And Taxes(25,573)(30,378)(16,937)(31,166)
Interest Expense455  457  477  492  
Income Before Tax(26,028)(30,835)(17,414)(31,658)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(26,028)(30,835)(17,414)(31,658)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (26,028) (30,835) (17,414) (31,658)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (26,028) (30,835) (17,414) (31,658)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.